| For: | Wang HD, Ren J, Zhang L. CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol 2004; 10(21): 3088-3093 [PMID: 15457549 DOI: 10.3748/wjg.v10.i21.3088] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i21/3088.htm |
| Number | Citing Articles |
| 1 |
Bo Chen, Yong Zhou, Ping Yang, Liu Liu, Xian-Peng Qin, Xiao-Ting Wu. CDH1 −160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine 2011; 55(2) doi: 10.1016/j.cyto.2011.04.008
|
| 2 |
Henriette Andersen, Jakob Mejlvang, Shaukat Mahmood, Irina Gromova, Pavel Gromov, Eugene Lukanidin, Marina Kriajevska, J. Kilian Mellon, Eugene Tulchinsky. Immediate and Delayed Effects of E-Cadherin Inhibition on Gene Regulation and Cell Motility in Human Epidermoid Carcinoma Cells. Molecular and Cellular Biology 2005; 25(20) doi: 10.1128/MCB.25.20.9138-9150.2005
|
| 3 |
Aeyung Kim, Minsik Son, Keun Il Kim, Young Yang, Eun Young Song, Hee Gu Lee, Jong-Seok Lim. Elevation of intracellular cyclic AMP inhibits NF-κB-mediated thymosin β4 expression in melanoma cells. Experimental Cell Research 2009; 315(19) doi: 10.1016/j.yexcr.2009.05.024
|
| 4 |
Jung Hyun Lee, Seok-Hyung Kim, Li-Hui Wang, Yoon-La Choi, Young Chul Kim, Jin Hee Kim, Tae Sung Park, Yun-Chul Hong, Young Kee Shin. Clinical Significance of CD99 Down-Regulation in Gastric Adenocarcinoma. Clinical Cancer Research 2007; 13(9) doi: 10.1158/1078-0432.CCR-06-1785
|
| 5 |
Jeffrey A. Norton, Christine M. Ham, Jacques Van Dam, R Brooke Jeffrey, Teri A. Longacre, David G. Huntsman, Nicki Chun, Allison W. Kurian, James M. Ford. CDH1 Truncating Mutations in the E-Cadherin Gene. Annals of Surgery 2007; 245(6) doi: 10.1097/01.sla.0000254370.29893.e4
|
| 6 |
L. M. Bergman, J. P. Blaydes. C-terminal binding proteins: Emerging roles in cell survival and tumorigenesis. Apoptosis 2006; 11(6) doi: 10.1007/s10495-006-6651-4
|
| 7 |
L. GAO, A. NIETERS, H. BRENNER. Meta‐analysis: tumour invasion‐related genetic polymorphisms and gastric cancer susceptibility. Alimentary Pharmacology & Therapeutics 2008; 28(5) doi: 10.1111/j.1365-2036.2008.03760.x
|
| 8 |
Lauren McAuley, Lydia O’Sullivan, Liam Grogan, Adrian Murphy, Christina Skourou, Brendan Curran, Deborah McNamara, Joanna Fay, Brian O’Neill, Bryan T. Hennessy, Sinead Toomey, Simon J. Furney. Whole genome sequencing of pre-treatment and post-treatment locally advanced rectal cancer using long and short read technologies. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-54265-x
|
| 9 |
Ian J Majewski, Irma Kluijt, Annemieke Cats, Thomas S Scerri, Daphne de Jong, Roelof JC Kluin, Samantha Hansford, Frans BL Hogervorst, Astrid J Bosma, Ingrid Hofland, Marcel Winter, David Huntsman, Jos Jonkers, Melanie Bahlo, René Bernards. An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. The Journal of Pathology 2013; 229(4) doi: 10.1002/path.4152
|
| 10 |
Jihui Li, Etwar McBean, Xinxiang Li, Mariana Berho, Samuel Szomstein, Raul J. Rosenthal. Laparoscopic Prophylactic Total Gastrectomy With Linear Stapler Side-to-Side Esophagojejunal Anastomosis for Hereditary Diffuse Gastric Cancer Syndrome in 2 Siblings. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2013; 23(3) doi: 10.1097/SLE.0b013e3182773e38
|
| 11 |
Marica Garziera, Valli De Re, Silvano Geremia, Raquel Seruca, Joana Figueiredo, Soraia Melo, Joana Simões-Correia, Laura Caggiari, Mariangela De Zorzi, Vincenzo Canzonieri, Renato Cannizzaro, Giuseppe Toffoli. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy. Clinical and Experimental Medicine 2013; 13(2) doi: 10.1007/s10238-012-0184-7
|
| 12 |
S Julien, I Puig, E Caretti, J Bonaventure, L Nelles, F van Roy, C Dargemont, A Garcia de Herreros, A Bellacosa, L Larue. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007; 26(53) doi: 10.1038/sj.onc.1210546
|
| 13 |
Yasuto Uchikado, Hiroshi Okumura, Sumiya Ishigami, Tetsuro Setoyama, Masataka Matsumoto, Tetsuhiro Owaki, Yoshiaki Kita, Shoji Natsugoe. Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer 2011; 14(1) doi: 10.1007/s10120-011-0004-x
|
| 14 |
William M. Rogers, Erika Dobo, Jeffrey A. Norton, Jacques Van Dam, R. Brooke Jeffrey, David G. Huntsman, Kerry Kingham, Nicki Chun, James M. Ford, Teri A. Longacre. Risk-reducing Total Gastrectomy for Germline Mutations in E-cadherin (CDH1): Pathologic Findings With Clinical Implications. American Journal of Surgical Pathology 2008; 32(6) doi: 10.1097/PAS.0b013e31815e7f1a
|
| 15 |
Miriam Barber, Rebecca C. Fitzgerald, Carlos Caldas. Familial gastric cancer – aetiology and pathogenesis. Best Practice & Research Clinical Gastroenterology 2006; 20(4) doi: 10.1016/j.bpg.2006.03.014
|
| 16 |
Jakob Mejlvang, Marina Kriajevska, Fedor Berditchevski, Igor Bronstein, Eugene M. Lukanidin, J. Howard Pringle, J. Kilian Mellon, Eugene M. Tulchinsky. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial–mesenchymal transition. Experimental Cell Research 2007; 313(2) doi: 10.1016/j.yexcr.2006.10.017
|
| 17 |
Mehmet Şahin, Emel Şahin, Saadet Gümüşlü, Abdullah Erdoğan, Meral Gültekin. DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer and Metastasis Reviews 2010; 29(4) doi: 10.1007/s10555-010-9253-0
|
| 18 |
Hui Jun Lim, Lizhe Zhuang, Rebecca C. Fitzgerald. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02622-3
|
| 19 |
Vanessa R. Blair. Familial Gastric Cancer: Genetics, Diagnosis, and Management. Surgical Oncology Clinics of North America 2012; 21(1) doi: 10.1016/j.soc.2011.09.003
|